Bio-Path Holdings, Inc. BPTH
Set alert
0.00 USD 0.00 0.00%
At close · Oct 29
0.21 +0.21 +71,300.00%
After hours · Oct 29, 4:00 PM ET
0.0001 Day range 0.0001
0.0001 52-week range 0.09853
- YTD
- -99.50%
- 1 year
- -99.67%
- Open
- 0.0001
- Prev close
- 0.0003
- Mkt cap
- 15.09K
- Vol
- 104
- Avg vol
- 33.73K
- EPS
- -1.14
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0001
- High
- 0.0001
- Forward P/E
- -0.26
- Beta
- 0.22
- Short ratio
- 0.03
- Inst. own
- 1.08%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Mar 8, 2024
- 50-d avg
- 0.8966
- 200-d avg
- 1.90
- 1y target
- 12.00
2Y chart
Events in this range
- Nov 14, 2024Earnings: -0.87; estimate -1.02; surprise 14.71%
Signals (110)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Sep 25, 2026 | 1 month ago |
| RSI: Oversold | Sep 10, 2026 | 1 month ago |
| RSI: Oversold | Sep 2, 2026 | 1 month ago |
| SMA: Bearish | Aug 17, 2026 | 2 months ago |
| SMA: Bullish | Aug 14, 2026 | 2 months ago |
| SMA: Bearish | Aug 7, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 7, 2026 | 2 months ago |
| SMA: Bullish | Aug 6, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 6, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 4, 2026 | 2 months ago |
| MACD: Buy Signal | Jul 21, 2026 | 3 months ago |
| SMA: Bullish | Jul 16, 2026 | 3 months ago |
| SMA: Bearish | Jul 15, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 15, 2026 | 3 months ago |
| SMA: Bullish | Jul 14, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 14, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 10, 2026 | 3 months ago |
| SMA: Bearish | Jul 7, 2026 | 3 months ago |
| SMA: Bullish | Jul 2, 2026 | 4 months ago |
| SMA: Bearish | Jul 1, 2026 | 4 months ago |
| SMA: Bullish | Jun 30, 2026 | 4 months ago |
| SMA: Bearish | Jun 17, 2026 | 4 months ago |
| SMA: Bullish | Jun 16, 2026 | 4 months ago |
| MACD: Buy Signal | May 27, 2026 | 5 months ago |
| RSI: Oversold | May 19, 2026 | 5 months ago |
| RSI: Oversold | May 13, 2026 | 5 months ago |
| MACD: Sell Signal | May 6, 2026 | 5 months ago |
| SMA: Bearish | May 5, 2026 | 5 months ago |
| SMA: Bullish | May 1, 2026 | 6 months ago |
| MACD: Buy Signal | May 1, 2026 | 6 months ago |
| SMA: Bearish | Apr 29, 2026 | 6 months ago |
| SMA: Bullish | Apr 28, 2026 | 6 months ago |
| SMA: Bearish | Apr 20, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 20, 2026 | 6 months ago |
| SMA: Bullish | Apr 15, 2026 | 6 months ago |
| SMA: Bearish | Apr 14, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 10, 2026 | 6 months ago |
| SMA: Bullish | Apr 9, 2026 | 6 months ago |
| SMA: Bearish | Apr 7, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 7, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 2, 2026 | 7 months ago |
| SMA: Bullish | Apr 1, 2026 | 7 months ago |
| SMA: Bearish | Mar 27, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 27, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 25, 2026 | 7 months ago |
| SMA: Bullish | Mar 23, 2026 | 7 months ago |
| SMA: Bearish | Mar 16, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 16, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 10, 2026 | 7 months ago |
| SMA: Bullish | Mar 6, 2026 | 7 months ago |
| SMA: Bearish | Mar 4, 2026 | 8 months ago |
| MACD: Sell Signal | Mar 4, 2026 | 8 months ago |
| SMA: Bullish | Mar 2, 2026 | 8 months ago |
| MACD: Buy Signal | Mar 2, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 27, 2026 | 8 months ago |
| SMA: Bearish | Feb 25, 2026 | 8 months ago |
| SMA: Bullish | Feb 18, 2026 | 8 months ago |
| SMA: Bearish | Feb 12, 2026 | 8 months ago |
| SMA: Bullish | Feb 10, 2026 | 8 months ago |
| SMA: Bearish | Feb 3, 2026 | 9 months ago |
| SMA: Bullish | Feb 2, 2026 | 9 months ago |
| SMA: Bearish | Jan 29, 2026 | 9 months ago |
| SMA: Bullish | Jan 28, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 21, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 16, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 15, 2026 | 9 months ago |
| MACD: Sell Signal | Dec 17, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 15, 2025 | 10 months ago |
| SMA: Bearish | Dec 12, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 12, 2025 | 10 months ago |
| SMA: Bullish | Dec 11, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 11, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 10, 2025 | 10 months ago |
| SMA: Bearish | Dec 9, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 8, 2025 | 10 months ago |
| SMA: Bullish | Dec 5, 2025 | 11 months ago |
| SMA: Bearish | Nov 25, 2025 | 11 months ago |
| SMA: Bullish | Nov 21, 2025 | 11 months ago |
| SMA: Bearish | Nov 20, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 17, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 14, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 11, 2025 | 11 months ago |
| SMA: Bullish | Oct 24, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 25, 2025 | 1 year ago |
| RSI: Oversold | Sep 11, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 9, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 2, 2025 | 1 year ago |
| RSI: Oversold | Aug 27, 2025 | 1 year ago |
| RSI: Oversold | Aug 25, 2025 | 1 year ago |
| RSI: Oversold | Aug 15, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 4, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 1, 2025 | 1 year ago |
| SMA: Bearish | Jun 30, 2025 | 1 year ago |
| SMA: Bullish | Jun 27, 2025 | 1 year ago |
| SMA: Bearish | Jun 26, 2025 | 1 year ago |
| SMA: Bullish | Jun 25, 2025 | 1 year ago |
| SMA: Bearish | Jun 24, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 23, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 4, 2025 | 1 year ago |
| SMA: Bearish | Jun 2, 2025 | 1 year ago |
| MACD: Sell Signal | May 30, 2025 | 1 year ago |
| SMA: Bullish | May 7, 2025 | 1 year ago |
| SMA: Bearish | May 6, 2025 | 1 year ago |
| SMA: Bullish | May 5, 2025 | 1 year ago |
| RSI: Oversold | Mar 21, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 6, 2025 | 1 year ago |
| RSI: Oversold | Feb 18, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 8, 2025 | 1 year ago |
| RSI: Overbought | Dec 19, 2024 | 1 year ago |
| RSI: Oversold | Dec 5, 2024 | 1 year ago |
Key statistics
- Market cap
- 4.48M
- Enterprise value
- -1.88M
- Trailing P/E
- 0.00
- Forward P/E
- -0.26
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 1.46
- EPS (TTM)
- -8.34
- Beta
- 0.22
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -3.87M
- Total cash
- 4.01M
- Total debt
- 55.00K
- Return on equity
- -366.18%
- Shares outstanding
- 4.31M
- Short % of float
- 2.10%
- 50-day average
- 0.8966
- 200-day average
- 1.90
Analyst view
Consensus: none
Price target (mean) 12.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy1
- Buy0
- Hold0
- Sell0
- Strong sell0
Next earnings
Mar 8, 2024
Expected Mar 8, 2024. Consensus EPS estimate -0.37.
Financials — quick view
BPTH Revenue — quarterly 0
BPTH Net income — quarterly -2.12M
BPTH EPS — quarterly -0.70
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 14, 2024 | Sep 1, 2024 | -1.02 | -0.87 | +0.15 | +14.71% |
| Aug 15, 2024 | Jun 1, 2024 | -1.54 | -1.16 | +0.38 | +24.68% |
| May 15, 2024 | Mar 1, 2024 | -4.54 | -4.88 | -0.34 | -7.49% |
| Mar 8, 2024 | Dec 1, 2023 | 0.00 | — | — | — |
| Nov 15, 2023 | Sep 1, 2023 | -6.80 | -6.40 | +0.40 | +5.88% |
| Aug 15, 2023 | Jun 1, 2023 | -10.40 | -10.60 | -0.20 | -1.92% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 8, 2024 | Roth MKM | reit | Buy | Buy |
| Apr 18, 2024 | Roth MKM | reit | Buy | Buy |
| Mar 27, 2024 | Roth MKM | main | Buy | Buy |
About Bio-Path Holdings, Inc.
Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. It is also developing BP1001-A that is in Phase I clinical trial for the treatment of solid tumors; Liposomal Bcl-2 (BP1002), which is in Phase I clinical trial for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; and Liposomal STAT3 (BP1003) for treating pancreatic cancer, non-small cell lung cancer, and AML. The company was founded in 2007 and is based in Bellaire, Texas.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- biopathholdings.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on BPTH — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Geode Capital Management, LLC | 0.32% | 13,598 | 14.14K | Sep 29, 2024 |
| Vanguard Group Inc | 0.31% | 13,502 | 14.04K | Sep 29, 2024 |
| Virtu Financial LLC | 0.29% | 12,325 | 12.82K | Sep 29, 2024 |
| Citadel Advisors Llc | 0.25% | 10,917 | 11.35K | Sep 29, 2024 |
| Tower Research Capital LLC (TRC) | 0.08% | 3,371 | 3.50K | Sep 29, 2024 |
| UBS Group AG | 0.07% | 2,856 | 2.97K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 0.31% | 13,502 | 14.04K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.28% | 11,963 | 12.44K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.01% | 485 | 504 | Oct 30, 2024 |
| Blackstone Alternative Multi-Strategy Fund | 0.00% | 1 | 1 | Sep 29, 2024 |
| Fidelity Total Market Index Fund | 0.00% | 170 | 176 | Oct 30, 2024 |